Skip to main content

Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: Technical, physiologic, and clinical issues

Journal of Nuclear Cardiology volume 8, pages 482–498 (2001)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Maublant J, Moins N, Gachon P. Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells. Eur J Nucl Med 1989; 15: 180–2.

    PubMed  CAS  Article  Google Scholar 

  2. Hunter DR, Haworth RA, Goknur AB, Hegge JO, Berkoff HA. Control of thallium and sodium fluxes in isolated adult rat heart cells by anthopleurin-A, verapamil and magnesium. J Mol Cell Cardiol 1986; 18: 1125–32.

    PubMed  CAS  Article  Google Scholar 

  3. Weich H, Strauss H, Pitt B. The extraction of thallium-201 by the myocardium. Circulation 1977; 56: 188–91.

    PubMed  CAS  Google Scholar 

  4. Backus M, Piwnica-Worms D, Hockett D, Kronauge J, Lieberman M, Ingram P, et al. Microprobe analysis of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential. Am J Physiol 1993; 265: C178–87.

    PubMed  CAS  Google Scholar 

  5. Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 1989; 65: 632–9.

    PubMed  CAS  Google Scholar 

  6. Marshall R, Leidholt E, Zhang DY, et al. Technetium-99m-hexakis 2- methoxy-2-isobutyl isonitrile and thallium-201 extraction, washout, and retention at varying coronary flow rates in rabbit heart. Circulation 1990; 82: 998–1007.

    PubMed  CAS  Google Scholar 

  7. Kelly JD, Forster AM, Higley B, Archer CM, Booker FS, Canning LR, et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med 1993; 34: 222–7.

    PubMed  CAS  Google Scholar 

  8. Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, et al. Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993; 34: 30–8.

    PubMed  CAS  Google Scholar 

  9. Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994; 35: 664–71.

    PubMed  CAS  Google Scholar 

  10. Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: comparison with 201Tl and regional myocardial blood flow. Circulation 1997; 96: 2332–8.

    PubMed  CAS  Google Scholar 

  11. Leppo JA, Meerdink DJ. Comparative myocardial extraction of two technetium-labeled BATO derivatives (SQ30217, SQ32014) and thallium. J Nucl Med 1990; 31: 67–74.

    PubMed  CAS  Google Scholar 

  12. Rumsey W, Rosenspire K, Nunn A. Myocardial extraction of teboroxime: effect of teboroxime interaction with blood. J Nucl Med 1992; 33: 94–101.

    PubMed  CAS  Google Scholar 

  13. Beanlands R, Muzik O, Nguyen N, Petry N, Schwaiger M. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol 1992; 20: 712–9.

    PubMed  CAS  Google Scholar 

  14. Vanzetto G, Fagret D, Pasqualini R, Mathieu J, Chossat F, Machecourt J. Biodistribution, dosimetry, and safety of myocardial perfusion imaging agent 99mTc-NOET in healthy volunteers. J Nucl Med 2000; 41: 141–8.

    PubMed  CAS  Google Scholar 

  15. Chang P, Shi Q-X, Saltzberg M, Maniawski P, Vitols P, Stubbs J, et al. Myocardial distribution and clearance of Tc99m-teboroxime during reperfusion after acute myocardial infarction. Circulation 1992; 86: I-707.

    Google Scholar 

  16. Calnon DA, Ruiz M, Vanzetto G, Watson DD, Beller GA, Glover DK. Myocardial uptake of (99m)Tc-N-NOET and (201)Tl during dobutamine infusion. Comparison with adenosine stress. Circulation 1999; 100: 1653–9.

    PubMed  CAS  Google Scholar 

  17. Glover DK, Ruiz M, Edwards NC, Cunningham M, Simanis JP, Smith WH, et al. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995; 91: 813–20.

    PubMed  CAS  Google Scholar 

  18. Sinusas A, Watson D, Cannon J, Beller G. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium- 99m-labeled methoxyisobutyl isonitrile and thallium-201. J Am Coll Cardiol 1989; 14: 1785–93.

    PubMed  CAS  Google Scholar 

  19. Canby R, Silber S, Pohost G. Relations of the myocardial imaging agents 99mTc-MIBI and 201Tl to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation 1990; 81: 289–96.

    PubMed  CAS  Google Scholar 

  20. Sinusas AJ, Shi Q, Saltzberg MT, Vitols P, Jain D, Wackers FJ, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia. J Nucl Med 1994; 35: 664–71.

    PubMed  CAS  Google Scholar 

  21. Verani M, Jeroudi M, Mahmarian J, Boyce T, Borges-Neto S, Patel B, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988; 12: 1573–81.

    PubMed  CAS  Google Scholar 

  22. Sinusas A, Trautman K, Bergin J, Watson D, Ruiz M, Smith W, et al. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile. Circulation 1990; 82: 1424–37.

    PubMed  CAS  Google Scholar 

  23. Freeman I, Grunwald A, Hoory S, Bodenheimer M. Effect of coronary occlusion and myocardial viability on myocardial activity of technetium-99m-sestamibi. J Nucl Med 1991; 32: 292–9.

    PubMed  CAS  Google Scholar 

  24. Glover DK, Ruiz M, Koplan BA, Watson DD, Beller GA. 99mTc-tetro- fosmin assessment of myocardial perfusion and viability in canine models of coronary occlusion and reperfusion. J Nucl Med 1999; 40: 142–9.

    PubMed  CAS  Google Scholar 

  25. Beller GA, Glover DK, Edwards NC, Ruiz M, Simanis JP, Watson DD. 99mTc-sestamibi uptake and retention during myocardial ischemia and reperfusion. Circulation 1993; 87: 2033–42.

    PubMed  CAS  Google Scholar 

  26. Moore CA, Cannon J, Watson DD, Kaul S, Beller GA. Thallium 201 kinetics in stunned myocardium characterized by severe postischemic systolic dysfunction. Circulation 1990; 81: 1622–32.

    PubMed  CAS  Google Scholar 

  27. Friedman B, Beihn R, Friedman J. The effect of hypoxia on thallium kinetics in cultured chick myocardial cells. J Nucl Med 1987; 28: 1453–60.

    PubMed  CAS  Google Scholar 

  28. Leppo JA, Macneil PB, Moring AF, Apstein CS. Separate effects of ischemia, hypoxia, and contractility on thallium-201 kinetics in rabbit myocardium. J Nucl Med 1986; 27: 66–74.

    PubMed  CAS  Google Scholar 

  29. Leppo J. Myocardial uptake of thallium and rubidium during alterations in perfusion and oxygenation in isolated rabbit hearts. J Nucl Med 1987; 28: 878–85.

    PubMed  CAS  Google Scholar 

  30. Maublant J. Kinetics on a cellular level. In: Zaret B, Beller G, editors. Nuclear cardiology: state of the art and future directions. St. Louis: Mosby; 1999. p. 13–26.

    Google Scholar 

  31. Sinusas AJ, Bergin JD, Edwards NC, Watson DD, Ruiz M, Makuch RW, et al. Redistribution of 99mTc-sestamibi and 201Tl in the presence of a severe coronary artery stenosis. Circulation 1994; 89: 2332–41.

    PubMed  CAS  Google Scholar 

  32. Li Q, Solot A, Frank T, Wagner H, Becker L. Myocardial redistribution of technetium-99m methoxy isobutyl isonitrile (SESTAMIBI). J Nucl Med 1990; 31: 1069–76.

    PubMed  CAS  Google Scholar 

  33. Taillefer R, Primeau M, Costi P, Lambert R, Leveille J, Latour Y. Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images. J Nucl Med 1991; 32: 1961–5.

    PubMed  CAS  Google Scholar 

  34. Sinusas A, Zaret B. Heart: coronary artery disease. In: Wagner H, Szaboz Z, editors. Principles of nuclear medicine. Philadelphia: Saunders; 1995. p. 789–819.

    Google Scholar 

  35. Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, et al. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose [published erratum appears in Circulation 1995; 91: 3026]. Circulation 1994; 89: 578–87.

    PubMed  CAS  Google Scholar 

  36. Maurea S, Cuocolo A, Soricelli A, Castelli L, Squame F, Imbriaco M, et al. Myocardial viability index in chronic coronary artery disease: technetium-99m-methoxy isobutyl isonitrile redistribution. J Nucl Med 1995; 36: 1953–60.

    PubMed  CAS  Google Scholar 

  37. Ghezzi C, Fagret D, Arvieux CC, Mathieu JP, Bontron R, Pasqualini R, et al. Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med 1995; 36: 1069–77.

    PubMed  CAS  Google Scholar 

  38. Johnson G III, Nguyen KN, Pasqualini R, Okada RD. Interaction of technetium-99m-N-NOET with blood elements: potential mechanism of myocardial redistribution. J Nucl Med 1997; 38: 138–43.

    PubMed  CAS  Google Scholar 

  39. Vanzetto G, Calnon DA, Ruiz M, Watson DD, Pasqualini R, Beller GA, et al. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow. Circulation 1997; 96: 2325–31.

    PubMed  CAS  Google Scholar 

  40. Petruzella F, Ruiz M, Katsiyiannis P, Watson DD, Pasqualini R, Beller GA, et al. Optimal timing for initial and redistribution technetium 99m- N-NOET image acquisition. J Nucl Cardiol 2000; 7: 123–31.

    PubMed  CAS  Article  Google Scholar 

  41. Wu JC, Yun JJ, Heller EN, Dione DP, DeMan P, Liu YH, et al. Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m- sestamibi imaging. J Nucl Med 1998; 39: 417–25.

    PubMed  CAS  Google Scholar 

  42. Calnon DA, Glover DK, Beller GA, Vanzetto G, Smith WH, Watson DD, et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing. Circulation 1997; 96: 2353–60.

    PubMed  CAS  Google Scholar 

  43. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301–11.

    PubMed  CAS  Google Scholar 

  44. Jain D, Wackers FJ, Mattera J, McMahon M, Sinusas AJ, Zaret BL. Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent: implications for a one-day imaging protocol. J Nucl Med 1993; 34: 1254–9.

    PubMed  CAS  Google Scholar 

  45. Kiat H, Maddahi J, Roy LT, Van Train K, Friedman J, Resser K, et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989; 117: 1–11.

    PubMed  CAS  Article  Google Scholar 

  46. Taillefer R, Lambert R, Dupras G, Gregoire J, Leveille J, Essiambre R, et al. Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. Eur J Nucl Med 1989; 15: 280–6.

    PubMed  CAS  Article  Google Scholar 

  47. Kahn J, McGhie I, Akers M, et al. Quantitative rotational tomography with Tl-201 and Tc99m 2-methoxy-isobutyl-isonitrile: a direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989; 79: 1282–93.

    PubMed  CAS  Google Scholar 

  48. Maddahi J, Kiat H, Friedman J, Berman D, Van Train K, Garcia E. Technetium-99m-sestamibi myocardial perfusion imaging for evaluation of coronary artery disease. In: Zaret B, Beller G, editors. Nuclear cardiology: state of the art and future directions. St. Louis: Mosby; 1993. p. 191–200.

    Google Scholar 

  49. Rozanski A, Diamond GA, Forrester JS, Berman DS, Morris D, Swan HJ. Alternative referent standards for cardiac normality: implications for diagnostic testing. Ann Intern Med 1984; 101: 164–71.

    PubMed  CAS  Google Scholar 

  50. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998; 280: 913–20.

    PubMed  CAS  Article  Google Scholar 

  51. Kymes S, Bruns D, Shaw L, Gillespie K, Fletcher J. Anatomy of a meta-analysis: a critical review of “Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance.” J Nucl Cardiol 2000; 7: 599–615.

    PubMed  CAS  Article  Google Scholar 

  52. Mannting F, Morgan-Mannting M. Gated SPECT with technetium- 99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med 1993; 34: 601–8.

    PubMed  CAS  Google Scholar 

  53. Depuey E, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med 1995; 36: 952–5.

    PubMed  CAS  Google Scholar 

  54. Ficaro EP, Fessler JA, Shreve PD, Kritzman JN, Rose PA, Corbett JR. Simultaneous transmission/emission myocardial perfusion tomography. Diagnostic accuracy of attenuation-corrected 99mTc-sestamibi single-photon emission computed tomography. Circulation 1996; 93: 463–73.

    PubMed  CAS  Google Scholar 

  55. Hendel RC, Berman DS, Cullom SJ, Follansbee W, Heller GV, Kiat H, et al. Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging. Circulation 1999; 99: 2742–9.

    PubMed  CAS  Google Scholar 

  56. Watson D, Smith W. Sestamibi and the tissue crosstalk. J Nucl Med 1990; 31: 1409–11.

    PubMed  CAS  Google Scholar 

  57. Garcia E, Cooke D, Van Train K, et al. Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi. Am J Cardiol 1990; 66: 23E-31E.

    PubMed  CAS  Article  Google Scholar 

  58. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol 1997; 29: 69–77.

    PubMed  CAS  Article  Google Scholar 

  59. Nakajima K, Taki J, Shuke N, Bunko H, Takata S, Hisada K. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. J Nucl Med 1993; 34: 1478–84.

    PubMed  CAS  Google Scholar 

  60. Sridhara B, Braat S, Rigo P, Itti R, Cload P, Lahiri A. Comparison of myocardial perfusion imaging with technetium-99m tetrofosmin versus thallium 201 in coronary artery disease. Am J Cardiol 1993; 72: 1015–9.

    PubMed  CAS  Article  Google Scholar 

  61. Heo J, Cave V, Wasserleben V, Iskandrian A. Planar and tomographic imaging with technetium 99m-labeled tetrofosmin: correlation with thallium-201 and coronary angiography. J Nucl Cardiol 1994; 1: 317–24.

    PubMed  CAS  Article  Google Scholar 

  62. Tamaki N, Takahashi N, Kawamoto M, Torizuka T, Tadamura E, Yonekura Y, et al. Myocardial tomography using technetium-99m- tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994; 35: 594–600.

    PubMed  CAS  Google Scholar 

  63. Rigo P, Leclercq B, Itti R, Lahiri A, Braat S. Technetium-99m- tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography. J Nucl Med 1994; 35: 587–93.

    PubMed  CAS  Google Scholar 

  64. Zaret BL, Rigo P, Wackers FJ, Hendel RC, Braat SH, Iskandrian AS, et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995; 91: 313–9.

    PubMed  CAS  Google Scholar 

  65. Cuocolo A, Soricelli A, Nicolai E, Squame F, Nappi A, Sullo P, et al. Technetium-99m-tetrofosmin regional myocardial uptake at rest: relation to severity of coronary artery stenosis in previous myocardial infarction. J Nucl Med 1995; 36: 907–13.

    PubMed  CAS  Google Scholar 

  66. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, et al. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease. Am J Cardiol 1996; 77: 350–4.

    PubMed  CAS  Article  Google Scholar 

  67. Benoit T, Vivegnis D, Lahiri A, Itti R, Braat S, Rigo P. Tomographic myocardial imaging with technetium-99m tetrofosmin. Comparison with tetrofosmin and thallium planar imaging and with angiography. Eur Heart J 1996; 17: 635–42.

    PubMed  CAS  Google Scholar 

  68. Khattar RS, Hendel RC, Crawley JC, Wackers FJ, Rigo P, Zaret BL, et al. Improved diagnostic accuracy of planar imaging with technetium 99m-labeled tetrofosmin compared with thallium-201 for the detection of coronary artery disease. J Nucl Cardiol 1997; 4: 291–7.

    PubMed  CAS  Article  Google Scholar 

  69. Shanoudy H, Raggi P, Beller GA, Soliman A, Ammermann EG, Kastner RJ, et al. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease. J Am Coll Cardiol 1998; 31: 331–7.

    PubMed  CAS  Article  Google Scholar 

  70. Azzarelli S, Galassi AR, Foti R, Mammana C, Musumeci S, Giuffrida G, Tamburino C. Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease. J Nucl Cardiol 1999; 6: 183–9.

    PubMed  CAS  Article  Google Scholar 

  71. Takahashi N, Tamaki N, Tadamura E, Kawamoto M, Torizuka T, Yonekura Y et al. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium-99m tetrofosmin. J Nucl Cardiol 1994; 1: 29–38.

    PubMed  CAS  Article  Google Scholar 

  72. Fagret D, Marie PY, Brunotte F, Giganti M, Le Guludec D, Bertrand A, et al. Myocardial perfusion imaging with technetium-99m-Tc NOET: comparison with thallium-201 and coronary angiography. J Nucl Med 1995; 36: 936–43.

    PubMed  CAS  Google Scholar 

  73. Larock MP, Cantineau R, Legrand V, Kulbertus H, Rigo P. 99mTc-MIBI (RP-30) to define the extent of myocardial ischemia and evaluate ventricular function. Eur J Nucl Med 1990; 16: 223–30.

    PubMed  CAS  Article  Google Scholar 

  74. Cramer MJ, Verzijlbergen JF, Van der Wall EE, Niemeyer MG, Zwinderman AH, Ascoop CA, et al. Head-to-head comparison between technetium-99m-sestamibi and thallium-201 tomographic imaging for the detection of coronary artery disease using combined dipyridamole-exercise stress. Coron Artery Dis 1994; 5: 787–91.

    PubMed  CAS  Google Scholar 

  75. Amanullah AM, Kiat H, Friedman JD, Berman DS. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 1996; 27: 803–9.

    PubMed  CAS  Article  Google Scholar 

  76. Candell-Riera J, Santana-Boado C, Castell-Conesa J, Aguade-Bruix S, Olona M, Palet J, et al. Simultaneous dipyridamole/maximal subjective exercise with 99mTc-MIBI SPECT: improved diagnostic yield in coronary artery disease. J Am Coll Cardiol 1997; 29: 531–6.

    PubMed  CAS  Article  Google Scholar 

  77. Pennell D, Underwood S, Swanton R, Walker J, Ell P. Dobutamine thallium myocardial perfusion tomography. J Am Coll Cardiol 1991; 15: 1471–9.

    Article  Google Scholar 

  78. Herman S, LaBresh K, Santos-Ocampo C, et al. Comparison of dobut- amine and exercise using technetium-99m sestamibi imaging for the evaluation of coronary artery disease. Am J Cardiol 1994; 73: 164–9.

    PubMed  CAS  Article  Google Scholar 

  79. Voth E, Baer F, Theissen P, Schneider C, Sechtem U, Schicha U. Dobutamine 99mTc-MIBI single-photon emission tomography: nonexercise-dependent detection of haemodynamically significant coronary artery stenoses. Eur J Nucl Med 1994; 21: 537–44.

    PubMed  CAS  Article  Google Scholar 

  80. Marwick T, Willemart B, D’Hondt AM, Baudhuin T, Wijns W, Detry JM, et al. Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography. Circulation 1993; 87: 345–54.

    PubMed  CAS  Google Scholar 

  81. Senior R, Sridhara BS, Anagnostou E, Handler C, Raftery EB, Lahiri A. Synergistic value of simultaneous stress dobutamine sestamibi single-photon-emission computerized tomography and echocardiography in the detection of coronary artery disease. Am Heart J 1994;128:713–8.

    PubMed  CAS  Article  Google Scholar 

  82. Mairesse GH, Marwick TH, Vanoverschelde JL, Baudhuin T, Wijns W, Melin JA, et al. How accurate is dobutamine stress electrocardiography for detection of coronary artery disease? Comparison with twodimensional echocardiography and technetium-99m methoxyl isobutyl isonitrile (mibi) perfusion scintigraphy. J Am Coll Cardiol 1994;24: 920–7.

    PubMed  CAS  Google Scholar 

  83. Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes de Leon C, et al. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol 1999;6:389–96.

    PubMed  CAS  Article  Google Scholar 

  84. Santos-Ocampo CD, Herman SD, Travin MI, Garber CE, Ahlberg AW, Messinger DE, et al. Comparison of exercise, dipyridamole, and adenosine by use of technetium 99m sestamibi tomographic imaging. J Nucl Cardiol 1994;1:57–64.

    PubMed  CAS  Article  Google Scholar 

  85. Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging. A diagnostic tool comes of age. Circulation 1991;83:363–81.

    PubMed  CAS  Google Scholar 

  86. Silverman K, Becker L, Bulkley B, Burow R, Mellits E, Kallman C, et al. Value of early thallium-201 scintigraphy for predicting mortality in patients with acute myocardial infarction. Circulation 1980;61:996–1003.

    PubMed  CAS  Google Scholar 

  87. Brown K, Boucher C, Okada R, Gurney T, Newell J, Strauss H, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994–1001.

    PubMed  CAS  Article  Google Scholar 

  88. Gibson R, Watson D, Craddock G, Crampton R, Kaiser D, Denny M, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321–36.

    PubMed  CAS  Google Scholar 

  89. Ladenheim M, Pollock B, Rozanski A, Berman D, Staniloff H, Forrester J, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464–71.

    PubMed  CAS  Google Scholar 

  90. Kaul S, Lilly D, Gascho J, Watson D, Gibson R, Oliner C, et al. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: comparison with cardiac catheterization. Circulation 1988;77:745–58.

    PubMed  CAS  Google Scholar 

  91. Wackers F, Russo D, Russon D, Clements J. Prognostic significance of normal quantitative planar thallium-201 stress scintigraphy in patients with chest pain. J Am Coll Cardiol 1985;6:27–30.

    PubMed  CAS  Google Scholar 

  92. Wahl J, Hakki A, Iskandrian A. Prognostic implications of normal exercise thallium-201 images. Arch Intern Med 1985;145:253–6.

    PubMed  CAS  Article  Google Scholar 

  93. Younis L, Byers S, Shaw L, Barth G, Goodgold H, Chaitman B. Prognostic importance of silent myocardial ischemia detected by intravenous dipyridamole thallium myocardial imaging in asymptomatic patients with coronary artery disease. J Am Coll Cardiol 1989;14:1635–41.

    PubMed  CAS  Article  Google Scholar 

  94. Hendel R, Layden J, Leppo J. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15:109–16.

    PubMed  CAS  Article  Google Scholar 

  95. Kaul S, Boucher C, Newell J, Chesler D, Greenberg J, Okada R, et al. Determination of the quantitative thallium imaging variables that optimize detection of coronary artery disease. J Am Coll Cardiol 1986;7:527–37.

    PubMed  CAS  Article  Google Scholar 

  96. Gill J, Ruddy T, Newell J, Finkelstein D, Straus H, Boucher C. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987;317:1486–9.

    PubMed  CAS  Google Scholar 

  97. Boucher C, Zir L, Beller G, Okada R, McKusick K, Strauss H, et al. Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol 1980;46:189–96.

    PubMed  CAS  Article  Google Scholar 

  98. Weiss A, Berman D, Lew A, Nielsen J, Potkin B, Swan H, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752–9.

    PubMed  CAS  Article  Google Scholar 

  99. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57–62.

    PubMed  CAS  Article  Google Scholar 

  100. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [published erratum appears in J Am Coll Cardiol 1996;27:756]. J Am Coll Cardiol 1995;26:639–47.

    PubMed  CAS  Article  Google Scholar 

  101. Marwick TH, Shaw LJ, Lauer MS, Kesler K, Hachamovitch R, Heller GV, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999;106:172–8.

    PubMed  CAS  Article  Google Scholar 

  102. Hachamovitch R, Berman DS, Kiat H, Bairey CN, Cohen I, Cabico A, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996;28:34–44.

    PubMed  CAS  Article  Google Scholar 

  103. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction [published erratum appears in Circulation 1998;98:190]. Circulation 1998;97:535–43.

    PubMed  CAS  Google Scholar 

  104. Berman DS, Kang X, Van Train KF, Lewin HC, Cohen I, Areeda J, et al. Comparative prognostic value of automatic quantitative analysis versus semiquantitative visual analysis of exercise myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1998;32:1987–95.

    PubMed  CAS  Article  Google Scholar 

  105. Mock M, Ringqvist I, Fisher L, Davis G, Alderman E, Ryan T, et al. Survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1982;66:562–8.

    PubMed  CAS  Google Scholar 

  106. Pryor D, Harrell F, Lee K, Rosati R, Coleman R, Cobb F, et al. Prognostic indicators for radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984;53:18–22.

    PubMed  CAS  Article  Google Scholar 

  107. Bonow R, Kent K, Rosing D, Lan K, Lakatos E, Borer J, et al. Exerciseinduced ischemia in mildly symptomatic patients with coronary artery disease and preserved left ventricular function: identification of subgroups at risk of death during medical therapy. N Engl J Med 1984;311:1339–45.

    PubMed  CAS  Google Scholar 

  108. Lee K, Pryor D, Pieper K, Harrell F, Califf R, Mark D, et al. Prognostic value of radionuclide angiography in medically treated patients with coronary artery disease: a comparison with clinical and catheterization variables. Circulation 1990;82:1705–17.

    PubMed  CAS  Google Scholar 

  109. Boucher C, Brewster D, Darling R, Okada R, Strauss H, Pohost G. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985;312:389–94.

    PubMed  CAS  Google Scholar 

  110. Eagle K, Coley C, Newell J, Brewster D, Darling R, Strauss H, et al. Combining clinical and thallium data optimized preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859–66.

    PubMed  CAS  Google Scholar 

  111. Mangano D, London M, Tubau J, Browner W, Hollenberg M, Krupski W, et al. and the Study of Perioperative Ischemia Research Group. Dipyridamole thallium-201 scintigraphy as a preoperative screening test: a reexamination of its predictive potential. Circulation 1991;84: 493–502.

    PubMed  CAS  Google Scholar 

  112. Multicenter Post-infarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med 1983;309:331–6.

    Article  Google Scholar 

  113. Leppo J, O’Brien J, Rothendler J, Getchell J, Lee V. Dipyridamolethallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014–8.

    PubMed  CAS  Google Scholar 

  114. DeCoster P, Wijns W, Cauwe F, Robert A, Beckers C, Melin J. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation 1990;82:2152–62.

    CAS  Google Scholar 

  115. Wackers F, Terrin M, Kayden D, Knatterud G, Forman S, Braunwald E, et al. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis In Myocardial Infarction (TIMI) trial. J Am Coll Cardiol 1989;13:998–1005.

    PubMed  CAS  Article  Google Scholar 

  116. Gibbons R, Verani M, Behrenbeck T, Pellikka P, O’Connor M, Mahmarian J, et al. Feasibility of tomographic 99mTc-hexakis-2- methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of acute treatment in myocardial infarction. Circulation 1989; 80: 1277–86.

    PubMed  CAS  Google Scholar 

  117. Faraggi M, Bok B. Role of technetium 99m methoxyisobutylisonitrile single photon emission tomography in the evaluation of thrombolysis in acute myocardial infarction before and after admission to hospital. Multicenter Study Group “Etude MIBI (EMIBI).” Eur J Nucl Med 1991; 18: 91–8.

    PubMed  CAS  Article  Google Scholar 

  118. Dewhurst N, Muir A. Comparative prognostic value of radionuclide ventriculography at rest and during exercise in 100 patients after first myocardial infarction. Br Heart J 1983; 49: 111–21.

    PubMed  CAS  Article  Google Scholar 

  119. Zaret BL, Wackers FJ, Terrin ML, Forman SA, Williams DO, Knatterud GL, et al. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol 1995; 26: 73–9.

    PubMed  CAS  Article  Google Scholar 

  120. Hung J, Goris M, Nash E, Kraemer H, DeBusk R, Berger WI, et al. Comparative value of maximal treadmill testing, exercise thallium myocardial perfusion scintigraphy and exercise radionuclide ventriculography for distinguishing high- and low-risk patients soon after acute myocardial infarction. Am J Cardiol 1984; 53: 1221–7.

    PubMed  CAS  Article  Google Scholar 

  121. Abraham R, Freedman S, Dunn R, Newman H, Roubin G, Harris P, et al. Prediction of multivessel coronary artery disease and prognosis early after acute myocardial infarction by exercise electrocardiography and thallium-201 myocardial perfusion scanning. Am J Cardiol 1986; 58: 423–7.

    PubMed  CAS  Article  Google Scholar 

  122. Becker L, Silverman K, Bulkley B, Kallman C, Mellits E, Weisfeldt M. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation 1983; 67: 1272–82.

    PubMed  CAS  Google Scholar 

  123. Gibson R, Watson D, Taylor G, Crosby I, Wellons H, Holt N, et al. Prospective assessment of regional myocardial perfusion before and after coronary revascularization surgery by quantitative thallium-201 scintigraphy. J Am Coll Cardiol 1983; 1: 804–15.

    PubMed  CAS  Article  Google Scholar 

  124. Kiat H, Berman DS, Maddahi J, De Yang L, Van Train K, Rozanski A, et al. Late reversibility of tomographic myocardial thallium-201 defects: an accurate marker of myocardial viability. J Am Coll Cardiol 1988; 12: 1456–63.

    PubMed  CAS  Article  Google Scholar 

  125. Dilsizian V, Rocco T, Freedman N, Leon M, Bonow R. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging. N Engl J Med 1990; 323: 141–6.

    PubMed  CAS  Google Scholar 

  126. Tilkemeier P, Guiney T, LaRaia P, Boucher C. Prognostic value of predischarge low level exercise thallium testing after thrombolytic treatment of acute myocardial infarction. Am J Cardiol 1990; 66: 1203–9.

    PubMed  CAS  Article  Google Scholar 

  127. Sutton J, Topol E. Significance of a negative exercise thallium test in the presence of a critical residual stenosis after thrombolysis for acute myocardial infarction. Circulation 1991; 83: 1278–86.

    PubMed  CAS  Google Scholar 

  128. Travin M, Dessouki A, Cameron T, Heller G. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995; 75: 665–9.

    PubMed  CAS  Article  Google Scholar 

  129. Brown K, Heller G, Landin R, Shaw L, Beller G, Pasquale M, et al. Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2-4 days after acute myocardial infarction predicts in-hospital and post-discharge cardiac events: comparison with submaximal exercise imaging. Circulation 1999; 100: 2060–6.

    PubMed  CAS  Google Scholar 

  130. Berger BC, Watson DD, Burwell LR, Crosby IK, Wellons HA, Teates CD, et al. Redistribution of thallium at rest in patients with stable and unstable angina and the effect of coronary artery bypass surgery. Circulation 1979; 60: 1114–25.

    PubMed  CAS  Google Scholar 

  131. Dilsizian V, Perrone-Filardi P, Arrighi JA, Bacharach SL, Quyyumi AA, Freedman NM, et al. Concordance and discordance between stressredistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography. Circulation 1993; 88: 941–52.

    PubMed  CAS  Google Scholar 

  132. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993; 87: 1630–41.

    PubMed  CAS  Google Scholar 

  133. Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL, et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTcsestamibi. Circulation 1994; 89: 2552–61.

    PubMed  CAS  Google Scholar 

  134. Sawada SG, Allman KC, Muzik O, Beanlands RS, Wolfe ER Jr, Gross M, et al. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects. J Am Coll Cardiol 1994; 23: 92–8.

    PubMed  CAS  Google Scholar 

  135. Altehoefer C, vom Dahl J, Biedermann M, Uebis R, Beilin I, Sheehan F, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med 1994; 35: 569–74.

    PubMed  CAS  Google Scholar 

  136. Maurea S, Cuocolo A, Pace L, Nicolai E, Nappi A, Imbriaco M, et al. Left ventricular dysfunction in coronary artery disease: comparison between rest-redistribution thallium 201 and resting technetium 99m methoxyisobutyl isonitrile cardiac imaging. J Nucl Cardiol 1994; 1: 65–71.

    PubMed  CAS  Article  Google Scholar 

  137. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol 1996; 27: 1592–7.

    PubMed  CAS  Article  Google Scholar 

  138. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B, et al. Functional assessment with electrocardiographic gated singlephoton emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999; 83: 1–5.

    PubMed  CAS  Article  Google Scholar 

  139. Galassi AR, Tamburino C, Grassi R, Foti R, Mammana C, Virgilio A, et al. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. J Nucl Cardiol 1998; 5: 56–63.

    PubMed  CAS  Article  Google Scholar 

  140. Flotats A, Carrio I, Estorch M, Berna L, Catafau AM, Mari C, et al. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Eur J Nucl Med 1997; 24: 767–73.

    PubMed  CAS  Google Scholar 

  141. Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, et al. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36: 1961–7.

    PubMed  CAS  Google Scholar 

  142. Cuocolo A, Nicolai E, Soricelli A, Pace L, Nappi A, Sullo P, et al. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. J Nucl Cardiol 1996; 3: 194–203.

    PubMed  CAS  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Departments of Diagnostic Radiology, Yale University School of Medicine, New Haven, Conn

    Purushothaman Kailasnath

  2. Departments of Diagnostic Medicine, Yale University School of Medicine, New Haven, Conn

    Albert J. Sinusas

Authors
  1. Purushothaman Kailasnath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Albert J. Sinusas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Albert J. Sinusas.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kailasnath, P., Sinusas, A.J. Comparison of Tl-201 with Tc-99m-labeled myocardial perfusion agents: Technical, physiologic, and clinical issues. J Nucl Cardiol 8, 482–498 (2001). https://doi.org/10.1067/mnc.2001.115078

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1067/mnc.2001.115078

Keywords

  • Single Photon Emission Compute Tomography
  • Myocardial Perfusion
  • Myocardial Perfusion Imaging
  • Nuclear Cardiology
  • Myocardial Viability